跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-2H
首页
药物
M-2H
M-2H
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CRYSTALLINE FORMS OF N-(1 -((2-(DIMETHYLAMINO)ETHYL)AMINO)-2-M ETHYL-1 -OOPROPAN-2-YL)-4-(4-(2-METHYL-5- (2S,3R,4R,5S,6R)-3,4,5-TRIHYDROXY-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-2-YL)BENZYL) PHENL)BUTANAMIDE AND METHODS OF THEIR SYNTHESIS
申请人: LEXICON PHARMACEUTICALS INC
优先权: 2018
CN
ANTI-TUMOR ACTIVITY OF AECHL-1, NOVEL TRITERPENOID ISOLATED FROM AILANTHUS EXCELSA IN VITRO AND IN VIVO
申请人: NAT CT FOR CELL SCIENCE
优先权: 2008
US
CASPASE-10 INHIBITORS FOR PREVENTION AND TREATMENT OF RETINOPATHY
申请人: MERCK PATENT GMBH
优先权: 2005
EP
Microbicidal agents
申请人: WACHTLER PETER
优先权: 2003
US
CCR-2 antagonist salt
申请人: MERCK & CO INC
优先权: 2004
CN
Antibacterial benzothiazole derivatives
申请人: ACTELION PHARMACEUTICALS LTD
优先权: 2014
CN
Thiazine and oxazine derivatives as MMP-13 inhibitors
申请人: GAUDILLIERE BERNARD
优先权: 2003
US
CRYSTALLINE FORMS OF AN MK2 INHIBITOR
申请人: XINTHERA INC
优先权: 2023
US
药物
反馈